The Brd-Inhibitor OTX015 Shows Pre-Clinical Activity in Anaplastic Large T-Cell Lymphoma (ALCL)

被引:1
|
作者
Boi, Michela [1 ]
Bonetti, Paola [1 ]
Ponzoni, Maurilio [2 ,3 ]
Tibiletti, Maria Grazia [4 ]
Stathis, Anastasios [5 ]
Cvitkovic, Esteban [6 ]
Inghirami, Giorgio [7 ]
Zucca, Emanuele [5 ]
Bertoni, Francesco [8 ]
机构
[1] IOR Inst Oncol Res, Lymphoma & Genom Res Program, Bellinzona, Switzerland
[2] Ist Sci San Raffaele, Pathol Unit, I-20132 Milan, Italy
[3] Ist Sci San Raffaele, Unit Lymphoid Malignancies, I-20132 Milan, Italy
[4] Insubria Univ, Varese, Italy
[5] IOSI Oncol Inst So Switzerland, Bellinzona, Switzerland
[6] OncoEthix SA, Lausanne, Switzerland
[7] Univ Turin, Ctr Expt Res & Med Studies, Turin, Italy
[8] Oncol Inst So Switzerland IOSI, Lymphoma Unit, Bellinzona, Switzerland
关键词
D O I
10.1182/blood.V120.21.4872.4872
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4872
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Aurora-A Kinase Distinguishes ALK plus Anaplastic Large Cell Lymphoma from ALK Negative and Cutaneous ALCL among Other T-Cell Lymphomas: Analysis of 72 Cases
    Shamanna, R. K.
    Medeiros, L. J.
    Whiteley, L.
    Schultz, D. S.
    Chitale, D. A.
    Inamdar, K. V.
    LABORATORY INVESTIGATION, 2009, 89 : 286A - 286A
  • [42] CD30-positive anaplastic large cell lymphoma (ALCL) of T-cell lineage in a 14-month-old infant with perinatally acquired HIV-1 infection
    Funkhouser, AW
    Katzman, PJ
    Sickel, JZ
    Lambert, JS
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1998, 20 (06) : 556 - 559
  • [43] Duvelisib (IPI-145), a Phosphoinositide-3-Kinase-δ,γ Inhibitor, Shows Activity in Patients with Relapsed/Refractory T-Cell Lymphoma
    Horwitz, Steven M.
    Porcu, Pierluigi
    Flinn, Ian
    Kahl, Brad S.
    Sweeney, Jennifer
    Stern, Howard M.
    Douglas, Mark
    Allen, Kerstin
    Kelly, Patrick
    Foss, Francine M.
    BLOOD, 2014, 124 (21)
  • [44] DIFFERENCES IN CLINICAL BEHAVIOR AND IMMUNOPHENOTYPE BETWEEN PRIMARY CUTANEOUS AND PRIMARY NODAL ANAPLASTIC LARGE-CELL LYMPHOMA OF T-CELL OR NULL-CELL PHENOTYPE
    DEBRUIN, PC
    BELJAARDS, RC
    VANHEERDE, P
    VANDERVALK, P
    NOORDUYN, LA
    VANKRIEKEN, JHJM
    KLUINNELEMANS, JC
    WILLEMZE, R
    MEIJER, CJLM
    HISTOPATHOLOGY, 1993, 23 (02) : 127 - 135
  • [45] Combinations containing the aza-anthracenedione pixantrone show pre-clinical activity in diffuse large B-cell lymphoma (DLBCL)
    Tarantelli, C.
    Gaudio, E.
    Kwee, I.
    Stathis, A.
    Zintl, P.
    Turton, M.
    Zucca, E.
    Bertoni, F.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 74 - 74
  • [46] HZ-R078: A tumor-enriched STAT3 degrader for treating T-cell lymphoma in pre-clinical models
    Wu, Yizhe
    Jin, Xinxin
    Zhou, Xinglu
    CANCER RESEARCH, 2023, 83 (07)
  • [47] Strategies to Develop Anti-KIR Mab Lacutamab in Patients with Peripheral T-Cell Lymphoma: Preliminary Monotherapy Clinical Data and Pre-Clinical Combinability Data
    Iyer, Swami P.
    Ayyappan, Sabarish R.
    Greenwell, Irl Brian
    Kim, Won Seog
    Lee, Seung Tae
    Kim, Jin Seok
    Lee, Won-Sik
    Jeon, Youngwoo
    Johnson, William
    Dave, Utpal P.
    Yoon, Sung-Soo
    Kang, Ka-Won
    Carrette, Florent
    Viotti, Julien
    Leyco, A. J.
    Muller, Marianna
    Horwitz, Steven M.
    BLOOD, 2023, 142
  • [48] A Novel JAK1 Mutant Breast Implant-Associated Anaplastic Large Cell Lymphoma Patient-Derived Xenograft Fostering Pre-Clinical Discoveries
    Fiore, Danilo
    Cappelli, Luca Vincenzo
    Zumbo, Paul
    Phillips, Jude M.
    Liu, Zhaoqi
    Cheng, Shuhua
    Yoffe, Liron
    Ghione, Paola
    Di Maggio, Federica
    Dogan, Ahmet
    Khodos, Inna
    de Stanchina, Elisa
    Casano, Joseph
    Kayembe, Clarisse
    Tam, Wayne
    Betel, Doron
    Foa, Robin
    Cerchietti, Leandro
    Rabadan, Raul
    Horwitz, Steven
    Weinstock, David M.
    Inghirami, Giorgio
    CANCERS, 2020, 12 (06) : 1 - 22
  • [49] DIFFERENCES IN CLINICAL BEHAVIOR, IMMUNOPHENOTYPE AND PRESENCE OF EBV BETWEEN PRIMARY CUTANEOUS AND PRIMARY NODAL LARGE CELL ANAPLASTIC LYMPHOMA OF T-CELL OR NULL-CELL PHENOTYPE
    DEBRUIN, PC
    BELJAARDS, RC
    VANKRIEKEN, HHJM
    WILLEMZE, R
    MEIJER, CJLM
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 100 (04) : 451 - 451
  • [50] NPM-ALK mimics thymic pre-T cell receptor (TCR) expansion but requires transient TCR expression for thymic egress and peripheral anaplastic large cell lymphoma (ALCL) development
    Malcolm, Tim
    Villarese, Patrick
    Fairbairn, Camilla
    Lamant, Laurence
    Trinquand, Amelie
    Hook, C. Elizabeth
    Burke, G. Amos
    Brugieres, Laurence
    Hughes, Katherine
    Payet, Dominique
    Merkel, Olaf
    Schiefer, Ana-Iris
    Mian, Shahid
    Wasik, Mariusz
    Turner, Martin
    Kenner, Lukas
    Asnafi, Vahid
    Macintyre, Elizabeth
    Turner, Suzanne D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 : 21 - 21